VM Pharma SRL
The score of VM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +12 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VM Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −17,906 € | ||||
| Equity | 242,551 € | ||||
| Cash | 54,967 € | ||||
| EBITDA | 52,597 € | ||||
| Total assets | 528,725 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Aug 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
VM Pharma's financial analysis
- Solvency45.9%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VM Pharma
VM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0743.948.725
- VAT number
- BE0743948725
- Peppol
- Registered · 0208:0743948725 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Feb 2020
- Registered office
- 1170 Watermael-Boitsfort
- Latest accounts
- 2025 · filed on 04 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
VM Pharma (SRL) has been based in Watermael-Boitsfort since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 17,906 € and equity of 242,551 €; its revenue is not published. Its solvency stands at 45.9%, above the median of its sector (37.8%).
Companies similar to VM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Stenenbrug Retail sale of pharmaceutical products Antwerp · balance sheet 528,859 €
- Pharmacie DE Robermont Retail sale of pharmaceutical products Liège · balance sheet 527,522 €
- LSRP Retail sale of pharmaceutical products Braives · balance sheet 527,233 €
- Rudophar Retail sale of pharmaceutical products Oostkamp · balance sheet 526,499 €
- Duran Zehra Retail sale of pharmaceutical products Ghent · balance sheet 531,335 €
- Smeets Farma Retail sale of pharmaceutical products Duffel · balance sheet 526,110 €
- Ghekiere Retail sale of pharmaceutical products Zemst · balance sheet 525,361 €
- Triple AAA Retail sale of pharmaceutical products Evere · balance sheet 532,534 €
Frequently asked questions about VM Pharma
What is the revenue of VM Pharma?
VM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0743948725 for VM Pharma, if the company is VAT-registered. Its company number (CBE) is 0743.948.725.
Where is the registered office of VM Pharma?
According to the CBE register, the registered office of VM Pharma is in 1170 Watermael-Boitsfort.
What is the equity of VM Pharma?
At the close of the 2025 financial year, the equity of VM Pharma amounts to 242,551 €, a solvency of 45.9% of total assets.
Who manages VM Pharma?
The register lists 1 active mandates at VM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →